102
Participants
Start Date
November 17, 2020
Primary Completion Date
July 19, 2022
Study Completion Date
December 20, 2022
HeartMate 3 Left Ventricular Assist System (HM3 LVAS)
This clinical trial investigates implant of the HM3 LVAS by techniques other than full median sternotomy.
Mount Sinai Hosptial, New York
New York-Presbyterian/Columbia University Medical Center, New York
University of Rochester Medical Center, Rochester
Penn State Milton S. Hershey Medical Center, Hershey
Hospital of the University of Pennsylvania, Philadelphia
Washington Hospital Center, Washington D.C.
Duke University Medical Center, Durham
Medical College of South Carolina, Charleston
Emory University Hospital, Atlanta
Shands at the University of Florida, Gainesville
AdventHealth Orlando, Orlando
Ohio State University, Columbus
St. Vincent Medical Group, Indianapolis
Spectrum Health Butterworth Hospital, Grand Rapids
University of Wisconsin, Madison
Minneapolis Heart Institute, Minneapolis
University of Minnesota Medical Center Fairview, Minneapolis
Northwestern Memorial Hospital, Chicago
Barnes-Jewish Hospital, St Louis
Kansas University Medical Center, Kansas City
University of Nebraska Medical Center, Omaha
Ochsner Medical Center, New Orleans
Baptist Health Medical Center, Little Rock
Integris Baptist Medical Center, Oklahoma City
University of Texas Southwestern Medical Center at Dallas, Dallas
Methodist Healthcare System of San Antonio, San Antonio
Cardiothoracic & Vascular Surgeons, Austin
University of Coloardo Hospital, Aurora
Stanford University Medical Center, Palo Alto
Sacred Heart Medical Center, Spokane
Tufts Medical Center, Boston
Foothills Medical Centre, Calgary
Lead Sponsor
Abbott Medical Devices
INDUSTRY